| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myeloproliferative Disorders | 56 | 2025 | 89 | 17.950 |
Why?
|
| Janus Kinase 2 | 60 | 2025 | 132 | 13.750 |
Why?
|
| Polycythemia Vera | 21 | 2025 | 39 | 5.250 |
Why?
|
| Hematopoietic Stem Cells | 24 | 2025 | 563 | 4.200 |
Why?
|
| Thrombocythemia, Essential | 15 | 2025 | 30 | 4.080 |
Why?
|
| Primary Myelofibrosis | 15 | 2025 | 50 | 4.020 |
Why?
|
| Thrombocytosis | 18 | 2015 | 34 | 3.720 |
Why?
|
| Mutation | 54 | 2025 | 6297 | 3.460 |
Why?
|
| Interferon-alpha | 3 | 2025 | 248 | 2.240 |
Why?
|
| Thrombopoietin | 18 | 2018 | 33 | 2.230 |
Why?
|
| Megakaryocytes | 10 | 2021 | 45 | 2.180 |
Why?
|
| Proto-Oncogene Proteins | 17 | 2019 | 616 | 2.080 |
Why?
|
| Hematologic Neoplasms | 8 | 2022 | 295 | 2.080 |
Why?
|
| Receptors, Thrombopoietin | 14 | 2023 | 31 | 1.540 |
Why?
|
| Polycythemia | 7 | 2025 | 44 | 1.500 |
Why?
|
| Mutation, Missense | 7 | 2020 | 930 | 1.420 |
Why?
|
| Hematopoiesis | 10 | 2024 | 229 | 1.410 |
Why?
|
| Thrombopoiesis | 5 | 2014 | 12 | 1.380 |
Why?
|
| Neoplasm Proteins | 9 | 2019 | 718 | 1.260 |
Why?
|
| Calreticulin | 9 | 2025 | 21 | 1.220 |
Why?
|
| Erythropoiesis | 3 | 2016 | 43 | 1.220 |
Why?
|
| Receptors, Cytokine | 10 | 2005 | 69 | 1.200 |
Why?
|
| Point Mutation | 8 | 2021 | 360 | 1.150 |
Why?
|
| Alleles | 10 | 2020 | 1705 | 1.140 |
Why?
|
| Mice | 47 | 2025 | 18909 | 1.120 |
Why?
|
| Amino Acid Substitution | 12 | 2020 | 412 | 1.040 |
Why?
|
| Interleukin-1beta | 3 | 2024 | 168 | 0.980 |
Why?
|
| Animals | 58 | 2025 | 36387 | 0.960 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 3 | 2024 | 160 | 0.960 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2025 | 25 | 0.940 |
Why?
|
| Bone Marrow Neoplasms | 3 | 2015 | 23 | 0.930 |
Why?
|
| Protein-Tyrosine Kinases | 6 | 2006 | 232 | 0.900 |
Why?
|
| Benzeneacetamides | 1 | 2024 | 8 | 0.900 |
Why?
|
| Erythropoietin | 5 | 2025 | 110 | 0.900 |
Why?
|
| Glutaminase | 1 | 2024 | 17 | 0.880 |
Why?
|
| Signal Transduction | 16 | 2019 | 4899 | 0.840 |
Why?
|
| Mice, Transgenic | 18 | 2021 | 2526 | 0.820 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2019 | 68 | 0.810 |
Why?
|
| Osteosclerosis | 1 | 2022 | 12 | 0.800 |
Why?
|
| Clone Cells | 6 | 2021 | 180 | 0.780 |
Why?
|
| Thrombocytopenia | 6 | 2014 | 235 | 0.720 |
Why?
|
| Erythroid Cells | 1 | 2020 | 24 | 0.700 |
Why?
|
| Humans | 105 | 2025 | 133935 | 0.700 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2021 | 111 | 0.700 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2022 | 569 | 0.690 |
Why?
|
| Disease Models, Animal | 9 | 2025 | 4777 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 19 | 2025 | 4822 | 0.660 |
Why?
|
| Bone Marrow Transplantation | 10 | 2024 | 621 | 0.660 |
Why?
|
| Pyrazoles | 4 | 2024 | 328 | 0.660 |
Why?
|
| Blood Platelets | 10 | 2014 | 341 | 0.650 |
Why?
|
| Loss of Heterozygosity | 5 | 2007 | 135 | 0.640 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 821 | 0.630 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 5 | 2013 | 102 | 0.620 |
Why?
|
| DNA-Binding Proteins | 6 | 2019 | 2161 | 0.610 |
Why?
|
| Exons | 8 | 2016 | 832 | 0.600 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2014 | 644 | 0.590 |
Why?
|
| Chromosomes, Human, X | 4 | 2007 | 161 | 0.580 |
Why?
|
| Pyrimidines | 6 | 2024 | 417 | 0.570 |
Why?
|
| Gene Deletion | 4 | 2018 | 809 | 0.570 |
Why?
|
| Hydroxyurea | 3 | 2013 | 86 | 0.550 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 115 | 0.540 |
Why?
|
| Frameshift Mutation | 1 | 2018 | 199 | 0.530 |
Why?
|
| Anemia | 2 | 2014 | 351 | 0.530 |
Why?
|
| Bone Marrow | 7 | 2021 | 335 | 0.510 |
Why?
|
| Valine | 5 | 2015 | 116 | 0.500 |
Why?
|
| Phenylalanine | 4 | 2015 | 129 | 0.480 |
Why?
|
| Germ-Line Mutation | 4 | 2019 | 368 | 0.480 |
Why?
|
| Clonal Evolution | 2 | 2020 | 49 | 0.470 |
Why?
|
| Receptors, Erythropoietin | 6 | 2015 | 13 | 0.470 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 510 | 0.460 |
Why?
|
| Microsatellite Repeats | 4 | 2018 | 240 | 0.460 |
Why?
|
| Protein Biosynthesis | 6 | 2024 | 676 | 0.460 |
Why?
|
| Cell Lineage | 5 | 2014 | 369 | 0.450 |
Why?
|
| Stem Cell Niche | 3 | 2021 | 58 | 0.430 |
Why?
|
| Mice, Knockout | 10 | 2022 | 3981 | 0.430 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 78 | 0.430 |
Why?
|
| Neoplasms | 4 | 2022 | 3027 | 0.430 |
Why?
|
| Female | 50 | 2025 | 71684 | 0.430 |
Why?
|
| STAT3 Transcription Factor | 2 | 2015 | 230 | 0.430 |
Why?
|
| Pedigree | 10 | 2025 | 1694 | 0.420 |
Why?
|
| Granulocytes | 6 | 2016 | 70 | 0.410 |
Why?
|
| Gene Expression Regulation | 5 | 2005 | 2656 | 0.410 |
Why?
|
| Polyethylene Glycols | 2 | 2025 | 252 | 0.410 |
Why?
|
| Leukemia | 3 | 2019 | 380 | 0.410 |
Why?
|
| DNA Mutational Analysis | 8 | 2020 | 838 | 0.400 |
Why?
|
| Platelet Factor 4 | 2 | 2017 | 23 | 0.400 |
Why?
|
| Myelodysplastic Syndromes | 3 | 2016 | 129 | 0.400 |
Why?
|
| Transgenes | 4 | 2014 | 346 | 0.400 |
Why?
|
| Male | 47 | 2025 | 65904 | 0.400 |
Why?
|
| Phenotype | 12 | 2023 | 4548 | 0.390 |
Why?
|
| Philadelphia Chromosome | 3 | 2009 | 43 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2008 | 34 | 0.370 |
Why?
|
| Hematology | 2 | 2012 | 41 | 0.370 |
Why?
|
| Receptors, Cell Surface | 5 | 2005 | 494 | 0.350 |
Why?
|
| RNA, Messenger | 10 | 2018 | 2902 | 0.340 |
Why?
|
| Promoter Regions, Genetic | 5 | 2012 | 1418 | 0.340 |
Why?
|
| Chromosome Aberrations | 4 | 2007 | 626 | 0.330 |
Why?
|
| Founder Effect | 1 | 2009 | 34 | 0.320 |
Why?
|
| Aged, 80 and over | 14 | 2020 | 7211 | 0.320 |
Why?
|
| Nitriles | 3 | 2022 | 155 | 0.320 |
Why?
|
| Middle Aged | 26 | 2025 | 29409 | 0.310 |
Why?
|
| Aged | 20 | 2025 | 21745 | 0.300 |
Why?
|
| Chromosome Deletion | 2 | 2008 | 664 | 0.290 |
Why?
|
| Thrombosis | 6 | 2025 | 539 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 3475 | 0.290 |
Why?
|
| Anemia, Refractory | 1 | 2008 | 7 | 0.290 |
Why?
|
| Anemia, Sideroblastic | 1 | 2008 | 17 | 0.280 |
Why?
|
| Adult | 26 | 2025 | 31950 | 0.280 |
Why?
|
| Intestinal Polyposis | 1 | 2007 | 18 | 0.280 |
Why?
|
| Mutant Proteins | 1 | 2007 | 118 | 0.280 |
Why?
|
| Base Sequence | 10 | 2016 | 3170 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 2122 | 0.270 |
Why?
|
| Smad4 Protein | 1 | 2007 | 58 | 0.270 |
Why?
|
| Iron | 2 | 2023 | 303 | 0.270 |
Why?
|
| STAT5 Transcription Factor | 3 | 2018 | 91 | 0.270 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2024 | 611 | 0.270 |
Why?
|
| Molecular Sequence Data | 12 | 2007 | 3967 | 0.270 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 82 | 0.260 |
Why?
|
| Gene Silencing | 2 | 2005 | 247 | 0.260 |
Why?
|
| Cell Differentiation | 6 | 2024 | 2025 | 0.260 |
Why?
|
| Thiazoles | 2 | 2018 | 102 | 0.250 |
Why?
|
| Carrier Proteins | 4 | 2005 | 1066 | 0.240 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2007 | 239 | 0.240 |
Why?
|
| Cytosol | 2 | 2024 | 168 | 0.230 |
Why?
|
| Adolescent | 15 | 2025 | 20536 | 0.230 |
Why?
|
| Flow Cytometry | 4 | 2014 | 836 | 0.230 |
Why?
|
| Homozygote | 5 | 2023 | 560 | 0.230 |
Why?
|
| Antigens, CD34 | 3 | 2021 | 112 | 0.230 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2024 | 63 | 0.220 |
Why?
|
| Cell Self Renewal | 1 | 2024 | 50 | 0.220 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 714 | 0.220 |
Why?
|
| Lentivirus | 1 | 2004 | 86 | 0.210 |
Why?
|
| Erythrocytes | 3 | 2016 | 236 | 0.210 |
Why?
|
| Dioxygenases | 3 | 2019 | 65 | 0.200 |
Why?
|
| Animals, Genetically Modified | 1 | 2024 | 339 | 0.200 |
Why?
|
| Platelet Membrane Glycoprotein IIb | 2 | 2021 | 6 | 0.200 |
Why?
|
| Recombinant Proteins | 2 | 2024 | 1438 | 0.190 |
Why?
|
| Genes, Dominant | 2 | 2018 | 254 | 0.190 |
Why?
|
| Amino Acid Sequence | 9 | 2011 | 2781 | 0.190 |
Why?
|
| Young Adult | 9 | 2025 | 9890 | 0.190 |
Why?
|
| Bone Marrow Cells | 4 | 2018 | 273 | 0.190 |
Why?
|
| DNA Methylation | 2 | 2019 | 1143 | 0.190 |
Why?
|
| Colony-Forming Units Assay | 3 | 2020 | 70 | 0.190 |
Why?
|
| Cell Nucleus | 1 | 2024 | 688 | 0.190 |
Why?
|
| Hemoglobins | 1 | 2023 | 321 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2020 | 1189 | 0.180 |
Why?
|
| Alternative Splicing | 5 | 2008 | 375 | 0.180 |
Why?
|
| Nestin | 2 | 2018 | 19 | 0.180 |
Why?
|
| Introns | 4 | 1999 | 313 | 0.180 |
Why?
|
| Gene Knock-In Techniques | 1 | 2021 | 127 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2016 | 449 | 0.170 |
Why?
|
| Cells, Cultured | 8 | 2019 | 3167 | 0.170 |
Why?
|
| Genetic Linkage | 2 | 2018 | 480 | 0.170 |
Why?
|
| Adenosine Triphosphate | 2 | 2024 | 295 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 4 | 2017 | 1102 | 0.160 |
Why?
|
| Genetic Markers | 3 | 2006 | 631 | 0.160 |
Why?
|
| Genetics, Medical | 1 | 2000 | 122 | 0.160 |
Why?
|
| Transaminases | 1 | 2019 | 36 | 0.160 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 1 | 1999 | 9 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2019 | 1606 | 0.160 |
Why?
|
| Hematopoietic System | 1 | 1999 | 7 | 0.160 |
Why?
|
| Reticulin | 1 | 2018 | 8 | 0.150 |
Why?
|
| Sympathomimetics | 1 | 2018 | 13 | 0.150 |
Why?
|
| Acetanilides | 1 | 2018 | 8 | 0.150 |
Why?
|
| Transcription, Genetic | 1 | 2024 | 1757 | 0.150 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 52 | 0.150 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2018 | 8 | 0.150 |
Why?
|
| Microvessels | 2 | 2016 | 64 | 0.150 |
Why?
|
| Haplotypes | 3 | 2009 | 562 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 1326 | 0.150 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 159 | 0.150 |
Why?
|
| Cell Line | 6 | 2017 | 2836 | 0.140 |
Why?
|
| Disease Progression | 3 | 2015 | 2242 | 0.140 |
Why?
|
| Oligonucleotides | 1 | 2018 | 92 | 0.140 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2017 | 36 | 0.140 |
Why?
|
| Prognosis | 4 | 2025 | 5081 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 1045 | 0.140 |
Why?
|
| Cytokines | 5 | 2011 | 1396 | 0.140 |
Why?
|
| Haploinsufficiency | 1 | 2019 | 274 | 0.140 |
Why?
|
| Hemostasis | 2 | 2007 | 70 | 0.140 |
Why?
|
| Sequence Deletion | 1 | 1999 | 537 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 324 | 0.140 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 73 | 0.130 |
Why?
|
| Platelet Count | 3 | 2013 | 144 | 0.130 |
Why?
|
| Erythroid Precursor Cells | 2 | 2008 | 24 | 0.130 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2016 | 21 | 0.130 |
Why?
|
| DNA, Complementary | 3 | 2008 | 472 | 0.130 |
Why?
|
| Crosses, Genetic | 2 | 2014 | 170 | 0.130 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 295 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 619 | 0.130 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 224 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 4 | 2011 | 1629 | 0.130 |
Why?
|
| Tissue Donors | 1 | 2020 | 525 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 3 | 2016 | 263 | 0.130 |
Why?
|
| Stem Cells | 2 | 2018 | 753 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2019 | 298 | 0.130 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2000 | 453 | 0.130 |
Why?
|
| RNA Splicing | 1 | 1998 | 250 | 0.130 |
Why?
|
| Phosphoproteins | 2 | 2010 | 456 | 0.130 |
Why?
|
| Integrases | 2 | 2007 | 163 | 0.130 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 104 | 0.120 |
Why?
|
| Milk Proteins | 1 | 1996 | 93 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2019 | 363 | 0.120 |
Why?
|
| Trans-Activators | 2 | 1999 | 830 | 0.120 |
Why?
|
| Heparin | 1 | 2017 | 225 | 0.120 |
Why?
|
| Antibodies | 1 | 2017 | 382 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2007 | 114 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2016 | 400 | 0.120 |
Why?
|
| Recombination, Genetic | 2 | 2007 | 452 | 0.120 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1995 | 13 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 202 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1996 | 151 | 0.120 |
Why?
|
| Genes, myc | 1 | 1995 | 107 | 0.120 |
Why?
|
| Autoimmune Diseases | 1 | 1997 | 279 | 0.120 |
Why?
|
| Myeloid Progenitor Cells | 1 | 2014 | 16 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2014 | 626 | 0.110 |
Why?
|
| Antigens, Ly | 1 | 2014 | 35 | 0.110 |
Why?
|
| Transplantation Chimera | 1 | 2014 | 44 | 0.110 |
Why?
|
| Leukocytes | 3 | 2018 | 225 | 0.110 |
Why?
|
| Survival Analysis | 2 | 2014 | 1596 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2016 | 121 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2014 | 65 | 0.110 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 62 | 0.110 |
Why?
|
| Enzyme Activation | 3 | 2015 | 644 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2014 | 119 | 0.110 |
Why?
|
| Isoantigens | 2 | 2005 | 25 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 2014 | 67 | 0.110 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 321 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2011 | 801 | 0.110 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 896 | 0.110 |
Why?
|
| Membrane Glycoproteins | 3 | 2010 | 432 | 0.110 |
Why?
|
| Genes, abl | 1 | 2013 | 7 | 0.110 |
Why?
|
| Chronic Disease | 4 | 2009 | 1254 | 0.110 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 823 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 2014 | 79 | 0.110 |
Why?
|
| DNA Repair | 1 | 2017 | 630 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 2 | 2005 | 280 | 0.110 |
Why?
|
| Receptors, Colony-Stimulating Factor | 1 | 1993 | 2 | 0.110 |
Why?
|
| Immunophenotyping | 1 | 2014 | 342 | 0.110 |
Why?
|
| Dasatinib | 1 | 2013 | 50 | 0.110 |
Why?
|
| Protein Binding | 4 | 2015 | 1832 | 0.110 |
Why?
|
| GPI-Linked Proteins | 2 | 2005 | 105 | 0.110 |
Why?
|
| Transduction, Genetic | 2 | 2018 | 296 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2014 | 438 | 0.100 |
Why?
|
| Tamoxifen | 1 | 2014 | 377 | 0.100 |
Why?
|
| Liver | 4 | 2025 | 1875 | 0.100 |
Why?
|
| COS Cells | 3 | 2015 | 283 | 0.100 |
Why?
|
| Models, Genetic | 3 | 2005 | 789 | 0.100 |
Why?
|
| Cell Division | 3 | 2011 | 774 | 0.100 |
Why?
|
| Receptors, Immunologic | 1 | 1993 | 123 | 0.100 |
Why?
|
| Fusion Proteins, bcr-abl | 2 | 2009 | 42 | 0.100 |
Why?
|
| Genes, Reporter | 2 | 2004 | 395 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 3751 | 0.090 |
Why?
|
| Dendritic Cells | 2 | 2006 | 448 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2015 | 781 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2014 | 1134 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2014 | 538 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2013 | 362 | 0.090 |
Why?
|
| Guanylate Cyclase | 1 | 2011 | 39 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 474 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 90 | 0.090 |
Why?
|
| Platelet Activation | 1 | 2011 | 71 | 0.090 |
Why?
|
| Hematologic Diseases | 1 | 2012 | 83 | 0.090 |
Why?
|
| DNA Damage | 1 | 2014 | 546 | 0.090 |
Why?
|
| DNA | 5 | 2008 | 1674 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 474 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2012 | 147 | 0.090 |
Why?
|
| Biomarkers | 2 | 2014 | 3426 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 999 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2014 | 509 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1599 | 0.090 |
Why?
|
| Child | 7 | 2025 | 25742 | 0.090 |
Why?
|
| Platelet Aggregation | 2 | 2007 | 125 | 0.080 |
Why?
|
| Lymphatic Vessels | 1 | 2010 | 37 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 76 | 0.080 |
Why?
|
| Gene Expression | 1 | 2014 | 1614 | 0.080 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2009 | 11 | 0.080 |
Why?
|
| DNA Primers | 2 | 2004 | 669 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2010 | 2940 | 0.080 |
Why?
|
| Sequence Analysis | 2 | 1999 | 54 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2025 | 813 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2016 | 14802 | 0.080 |
Why?
|
| Italy | 1 | 2009 | 126 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 234 | 0.080 |
Why?
|
| Transfection | 2 | 2004 | 1089 | 0.080 |
Why?
|
| STAT Transcription Factors | 1 | 2009 | 25 | 0.080 |
Why?
|
| Debrisoquin | 1 | 1988 | 1 | 0.080 |
Why?
|
| Receptors, Leptin | 3 | 1998 | 42 | 0.070 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 102 | 0.070 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 50 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 406 | 0.070 |
Why?
|
| Isoquinolines | 1 | 1988 | 42 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 392 | 0.070 |
Why?
|
| Poland | 1 | 2008 | 49 | 0.070 |
Why?
|
| Talin | 1 | 2007 | 11 | 0.070 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2007 | 9 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 401 | 0.070 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2007 | 7 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1988 | 142 | 0.070 |
Why?
|
| Integrins | 1 | 2007 | 103 | 0.070 |
Why?
|
| Hyperplasia | 1 | 2007 | 203 | 0.070 |
Why?
|
| Apoptosis | 3 | 2014 | 1930 | 0.070 |
Why?
|
| Binding Sites | 2 | 2024 | 1370 | 0.070 |
Why?
|
| Whole-Body Irradiation | 2 | 2018 | 61 | 0.070 |
Why?
|
| Family Health | 1 | 2008 | 267 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1910 | 0.070 |
Why?
|
| Stomach Diseases | 1 | 2007 | 57 | 0.070 |
Why?
|
| Infant | 2 | 2015 | 13163 | 0.070 |
Why?
|
| Polyps | 1 | 2007 | 44 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2007 | 90 | 0.070 |
Why?
|
| Gene Dosage | 1 | 2008 | 456 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 577 | 0.070 |
Why?
|
| Organ Specificity | 3 | 2011 | 444 | 0.060 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2006 | 94 | 0.060 |
Why?
|
| Transcription Factors | 2 | 1999 | 2704 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 2 | 2019 | 20 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 679 | 0.060 |
Why?
|
| Embryo, Mammalian | 2 | 2010 | 464 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 2 | 2019 | 32 | 0.060 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1999 | 153 | 0.060 |
Why?
|
| Glycosylation | 1 | 2025 | 127 | 0.060 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2005 | 93 | 0.060 |
Why?
|
| Proteins | 2 | 2003 | 1087 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2025 | 327 | 0.060 |
Why?
|
| CD4 Antigens | 1 | 2004 | 58 | 0.060 |
Why?
|
| Protein Sorting Signals | 1 | 2004 | 40 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 486 | 0.060 |
Why?
|
| CD40 Antigens | 1 | 2004 | 27 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 68 | 0.050 |
Why?
|
| Dipeptides | 1 | 2004 | 62 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2024 | 145 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 173 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 1984 | 86 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2004 | 166 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2025 | 241 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2016 | 5183 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2004 | 157 | 0.050 |
Why?
|
| Genes, p53 | 1 | 2004 | 234 | 0.050 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 217 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5511 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 429 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 527 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2003 | 54 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 611 | 0.050 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2025 | 232 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 697 | 0.050 |
Why?
|
| Genes, Regulator | 1 | 2002 | 57 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17487 | 0.050 |
Why?
|
| Cell Movement | 1 | 2006 | 916 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2004 | 452 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2004 | 717 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2009 | 3639 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2002 | 400 | 0.050 |
Why?
|
| Cell Survival | 1 | 2004 | 889 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 2807 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2008 | 1334 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2000 | 866 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2021 | 2539 | 0.040 |
Why?
|
| Tissue Scaffolds | 1 | 2021 | 85 | 0.040 |
Why?
|
| Sepsis | 1 | 2005 | 517 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2024 | 1132 | 0.040 |
Why?
|
| Peptides | 1 | 2004 | 859 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2021 | 164 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2022 | 295 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1735 | 0.040 |
Why?
|
| 5' Untranslated Regions | 1 | 2000 | 61 | 0.040 |
Why?
|
| Models, Biological | 1 | 2005 | 1532 | 0.040 |
Why?
|
| Ferritins | 1 | 2000 | 109 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2000 | 198 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 673 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 960 | 0.040 |
Why?
|
| Japan | 1 | 1999 | 156 | 0.040 |
Why?
|
| Finland | 1 | 2019 | 46 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 1999 | 45 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2015 | 1701 | 0.040 |
Why?
|
| Oncogene Protein v-akt | 2 | 2011 | 33 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 45 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 110 | 0.040 |
Why?
|
| Immunoglobulin D | 1 | 1978 | 6 | 0.040 |
Why?
|
| Amino Acids, Branched-Chain | 1 | 2019 | 83 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2022 | 6663 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 399 | 0.040 |
Why?
|
| Telomere | 1 | 2020 | 230 | 0.040 |
Why?
|
| Biomimetics | 1 | 2018 | 18 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 225 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 693 | 0.040 |
Why?
|
| Bioreactors | 1 | 2018 | 44 | 0.040 |
Why?
|
| Respiratory Hypersensitivity | 1 | 1978 | 54 | 0.040 |
Why?
|
| K562 Cells | 1 | 2018 | 100 | 0.040 |
Why?
|
| Phthalazines | 1 | 2017 | 15 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 233 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1997 | 158 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 239 | 0.030 |
Why?
|
| Ligands | 1 | 1999 | 572 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 327 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 199 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 1997 | 286 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 250 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 292 | 0.030 |
Why?
|
| Glycoproteins | 1 | 1999 | 379 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 690 | 0.030 |
Why?
|
| Fibrosis | 1 | 2018 | 461 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2019 | 456 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2018 | 184 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 1996 | 38 | 0.030 |
Why?
|
| Hypothalamus | 1 | 1998 | 219 | 0.030 |
Why?
|
| Immune Sera | 1 | 1996 | 95 | 0.030 |
Why?
|
| Radiation Injuries, Experimental | 1 | 1996 | 23 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 72 | 0.030 |
Why?
|
| Piperazines | 1 | 2017 | 257 | 0.030 |
Why?
|
| Leptin | 1 | 1997 | 225 | 0.030 |
Why?
|
| GATA1 Transcription Factor | 1 | 1995 | 9 | 0.030 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 1995 | 5 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 407 | 0.030 |
Why?
|
| Proteolysis | 1 | 2016 | 193 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1999 | 1123 | 0.030 |
Why?
|
| Rabbits | 1 | 1996 | 736 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2006 | 129 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2016 | 271 | 0.030 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2014 | 6 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 317 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 253 | 0.030 |
Why?
|
| Capillaries | 1 | 2014 | 70 | 0.030 |
Why?
|
| Photons | 1 | 2014 | 53 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2015 | 116 | 0.030 |
Why?
|
| Growth Inhibitors | 1 | 1994 | 40 | 0.030 |
Why?
|
| Genomics | 1 | 2022 | 1675 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1999 | 869 | 0.030 |
Why?
|
| Rats | 2 | 1998 | 3883 | 0.030 |
Why?
|
| Microcirculation | 1 | 2014 | 118 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 501 | 0.030 |
Why?
|
| Lymphokines | 1 | 1994 | 69 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2000 | 1833 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2014 | 68 | 0.030 |
Why?
|
| Thromboembolism | 1 | 2014 | 91 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1994 | 105 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2014 | 151 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2014 | 129 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 773 | 0.030 |
Why?
|
| Testis | 1 | 1996 | 426 | 0.030 |
Why?
|
| Optics and Photonics | 1 | 2014 | 143 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 337 | 0.030 |
Why?
|
| Arteries | 1 | 2014 | 229 | 0.030 |
Why?
|
| Chemokines | 1 | 2013 | 138 | 0.030 |
Why?
|
| Interleukin-4 | 1 | 1993 | 147 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 334 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 467 | 0.030 |
Why?
|
| Mitoxantrone | 1 | 2012 | 27 | 0.030 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2014 | 233 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2014 | 167 | 0.020 |
Why?
|
| Erythroblasts | 1 | 2012 | 5 | 0.020 |
Why?
|
| Anemia, Hemolytic, Congenital | 1 | 2012 | 3 | 0.020 |
Why?
|
| Genes, Synthetic | 1 | 2012 | 12 | 0.020 |
Why?
|
| Etoposide | 1 | 2012 | 120 | 0.020 |
Why?
|
| Radiation Chimera | 1 | 2012 | 18 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2012 | 11 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 323 | 0.020 |
Why?
|
| Recombinases | 1 | 2012 | 25 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2012 | 77 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1994 | 397 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 1993 | 911 | 0.020 |
Why?
|
| Leukopenia | 1 | 2012 | 48 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 1994 | 454 | 0.020 |
Why?
|
| Soluble Guanylyl Cyclase | 1 | 2011 | 7 | 0.020 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2011 | 9 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 352 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2014 | 1006 | 0.020 |
Why?
|
| Polyploidy | 1 | 2011 | 19 | 0.020 |
Why?
|
| Protein Folding | 1 | 2012 | 220 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2011 | 105 | 0.020 |
Why?
|
| Europe | 1 | 2012 | 384 | 0.020 |
Why?
|
| Leukocytosis | 1 | 2011 | 48 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 149 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2011 | 374 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1484 | 0.020 |
Why?
|
| Endothelium, Lymphatic | 1 | 2010 | 10 | 0.020 |
Why?
|
| Risk Factors | 1 | 2025 | 11100 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 302 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2012 | 222 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2011 | 484 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 395 | 0.020 |
Why?
|
| Blood Vessels | 1 | 2010 | 108 | 0.020 |
Why?
|
| World Health Organization | 1 | 2009 | 118 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1197 | 0.020 |
Why?
|
| Calibration | 1 | 2008 | 100 | 0.020 |
Why?
|
| Kidney | 1 | 1996 | 1417 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1988 | 122 | 0.020 |
Why?
|
| Integrin alpha2beta1 | 1 | 2007 | 8 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2011 | 490 | 0.020 |
Why?
|
| Leukemia, Lymphoid | 1 | 1988 | 110 | 0.020 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1988 | 50 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 1988 | 52 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2163 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2007 | 29 | 0.020 |
Why?
|
| X Chromosome Inactivation | 1 | 2008 | 64 | 0.020 |
Why?
|
| Integrin beta1 | 1 | 2007 | 56 | 0.020 |
Why?
|
| Reference Standards | 1 | 2008 | 245 | 0.020 |
Why?
|
| Bleeding Time | 1 | 2007 | 8 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2007 | 64 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1976 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2007 | 78 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2008 | 244 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2010 | 522 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2010 | 545 | 0.020 |
Why?
|
| Type C Phospholipases | 1 | 2006 | 29 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2013 | 1094 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 732 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 1146 | 0.020 |
Why?
|
| Heterozygote | 1 | 1988 | 718 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 97 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 115 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2006 | 262 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 1761 | 0.010 |
Why?
|
| Chemokine CCL22 | 1 | 2004 | 6 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2004 | 28 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2006 | 778 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2004 | 63 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 351 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2004 | 65 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 13010 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1153 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2004 | 122 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2004 | 174 | 0.010 |
Why?
|
| Brain | 1 | 1996 | 3221 | 0.010 |
Why?
|
| Chickens | 1 | 1984 | 640 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1984 | 231 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 212 | 0.010 |
Why?
|
| Species Specificity | 1 | 1984 | 570 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 1850 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 1736 | 0.010 |
Why?
|
| Monocytes | 1 | 2004 | 361 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2004 | 482 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 3056 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 1720 | 0.010 |
Why?
|
| Swine | 1 | 1984 | 1216 | 0.010 |
Why?
|
| Goosecoid Protein | 1 | 1999 | 4 | 0.010 |
Why?
|
| Cosmids | 1 | 1999 | 48 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1999 | 100 | 0.010 |
Why?
|
| Radioallergosorbent Test | 1 | 1978 | 7 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 1002 | 0.010 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 1978 | 25 | 0.010 |
Why?
|
| Myocardium | 1 | 1984 | 1045 | 0.010 |
Why?
|
| Mitochondria | 1 | 1984 | 746 | 0.010 |
Why?
|
| Supraoptic Nucleus | 1 | 1998 | 4 | 0.010 |
Why?
|
| Vasopressins | 1 | 1998 | 45 | 0.010 |
Why?
|
| Receptors, Somatostatin | 1 | 1998 | 56 | 0.010 |
Why?
|
| Arcuate Nucleus of Hypothalamus | 1 | 1998 | 38 | 0.010 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1998 | 52 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1978 | 179 | 0.010 |
Why?
|
| Oxytocin | 1 | 1998 | 73 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1998 | 433 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 1999 | 584 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1998 | 1310 | 0.010 |
Why?
|
| Sex Factors | 1 | 1978 | 1383 | 0.010 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 13 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1994 | 28 | 0.010 |
Why?
|
| Hypergammaglobulinemia | 1 | 1994 | 11 | 0.010 |
Why?
|
| Blood | 1 | 1994 | 105 | 0.010 |
Why?
|
| Epithelium | 1 | 1994 | 370 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1998 | 729 | 0.010 |
Why?
|
| Age Factors | 1 | 1978 | 2979 | 0.010 |
Why?
|
| Asthma | 1 | 1978 | 812 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1994 | 941 | 0.000 |
Why?
|
| Mixed Function Oxygenases | 1 | 1988 | 35 | 0.000 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 1988 | 34 | 0.000 |
Why?
|
| Neurons | 1 | 1998 | 2035 | 0.000 |
Why?
|
| T-Lymphocytes | 1 | 1994 | 1814 | 0.000 |
Why?
|